These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 19604267)

  • 1. Differences in virulence and immune response induced in a murine model by isolates of Mycobacterium ulcerans from different geographic areas.
    Ortiz RH; Leon DA; Estevez HO; Martin A; Herrera JL; Romo LF; Portaels F; Pando RH
    Clin Exp Immunol; 2009 Aug; 157(2):271-81. PubMed ID: 19604267
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heterogeneity of mycolactones produced by clinical isolates of Mycobacterium ulcerans: implications for virulence.
    Mve-Obiang A; Lee RE; Portaels F; Small PL
    Infect Immun; 2003 Feb; 71(2):774-83. PubMed ID: 12540557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mycolactone-mediated inhibition of tumor necrosis factor production by macrophages infected with Mycobacterium ulcerans has implications for the control of infection.
    Torrado E; Adusumilli S; Fraga AG; Small PL; Castro AG; Pedrosa J
    Infect Immun; 2007 Aug; 75(8):3979-88. PubMed ID: 17517872
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cellular immunity confers transient protection in experimental Buruli ulcer following BCG or mycolactone-negative Mycobacterium ulcerans vaccination.
    Fraga AG; Martins TG; Torrado E; Huygen K; Portaels F; Silva MT; Castro AG; Pedrosa J
    PLoS One; 2012; 7(3):e33406. PubMed ID: 22413022
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mycolactone gene expression is controlled by strong SigA-like promoters with utility in studies of Mycobacterium ulcerans and buruli ulcer.
    Tobias NJ; Seemann T; Pidot SJ; Porter JL; Marsollier L; Marion E; Letournel F; Zakir T; Azuolas J; Wallace JR; Hong H; Davies JK; Howden BP; Johnson PD; Jenkin GA; Stinear TP
    PLoS Negl Trop Dis; 2009 Nov; 3(11):e553. PubMed ID: 19936295
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disseminated
    Hammoudi N; Dizoe AS; Regoui S; Davoust B; Drancourt M; Bouam A
    Am J Trop Med Hyg; 2019 Sep; 101(3):491-493. PubMed ID: 31333157
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mycobacterium ulcerans-Bordetella trematum chronic tropical cutaneous ulcer: A four-case series, Côte d'Ivoire.
    Tchan BGO; Kakou-Ngazoa S; Dizoe S; Hammoudi N; Grine G; Ruimy R; Drancourt M
    PLoS Negl Trop Dis; 2023 Dec; 17(12):e0011413. PubMed ID: 38060465
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The One That Got Away: How Macrophage-Derived IL-1β Escapes the Mycolactone-Dependent Sec61 Blockade in Buruli Ulcer.
    Hall BS; Hsieh LT; Sacre S; Simmonds RE
    Front Immunol; 2021; 12():788146. PubMed ID: 35154073
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mycolactone: a polyketide toxin from Mycobacterium ulcerans required for virulence.
    George KM; Chatterjee D; Gunawardana G; Welty D; Hayman J; Lee R; Small PL
    Science; 1999 Feb; 283(5403):854-7. PubMed ID: 9933171
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microbiology of secondary infections in Buruli ulcer lesions; implications for therapeutic interventions.
    Gyamfi E; Narh CA; Quaye C; Abbass A; Dzudzor B; Mosi L
    BMC Microbiol; 2021 Jan; 21(1):4. PubMed ID: 33402095
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Local and regional re-establishment of cellular immunity during curative antibiotherapy of murine Mycobacterium ulcerans infection.
    Martins TG; Gama JB; Fraga AG; Saraiva M; Silva MT; Castro AG; Pedrosa J
    PLoS One; 2012; 7(2):e32740. PubMed ID: 22393444
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vaccination with the Surface Proteins MUL_2232 and MUL_3720 of Mycobacterium ulcerans Induces Antibodies but Fails to Provide Protection against Buruli Ulcer.
    Bolz M; Bénard A; Dreyer AM; Kerber S; Vettiger A; Oehlmann W; Singh M; Duthie MS; Pluschke G
    PLoS Negl Trop Dis; 2016 Feb; 10(2):e0004431. PubMed ID: 26849213
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mycobacterium ulcerans toxic macrolide, mycolactone modulates the host immune response and cellular location of M. ulcerans in vitro and in vivo.
    Adusumilli S; Mve-Obiang A; Sparer T; Meyers W; Hayman J; Small PL
    Cell Microbiol; 2005 Sep; 7(9):1295-304. PubMed ID: 16098217
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mycolactone diffuses from Mycobacterium ulcerans-infected tissues and targets mononuclear cells in peripheral blood and lymphoid organs.
    Hong H; Coutanceau E; Leclerc M; Caleechurn L; Leadlay PF; Demangel C
    PLoS Negl Trop Dis; 2008; 2(10):e325. PubMed ID: 18941518
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mycobacterium ulcerans triggers T-cell immunity followed by local and regional but not systemic immunosuppression.
    Fraga AG; Cruz A; Martins TG; Torrado E; Saraiva M; Pereira DR; Meyers WM; Portaels F; Silva MT; Castro AG; Pedrosa J
    Infect Immun; 2011 Jan; 79(1):421-30. PubMed ID: 20974825
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Buruli ulcer and mycolactone-producing mycobacteria.
    Nakanaga K; Yotsu RR; Hoshino Y; Suzuki K; Makino M; Ishii N
    Jpn J Infect Dis; 2013; 66(2):83-8. PubMed ID: 23514902
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induced Synthesis of Mycolactone Restores the Pathogenesis of
    Strong E; Hart B; Wang J; Orozco MG; Lee S
    Front Immunol; 2022; 13():750643. PubMed ID: 35401531
    [No Abstract]   [Full Text] [Related]  

  • 18. Infection with Mycobacterium ulcerans induces persistent inflammatory responses in mice.
    Oliveira MS; Fraga AG; Torrado E; Castro AG; Pereira JP; Filho AL; Milanezi F; Schmitt FC; Meyers WM; Portaels F; Silva MT; Pedrosa J
    Infect Immun; 2005 Oct; 73(10):6299-310. PubMed ID: 16177301
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    Tchan BGO; Ngazoa-Kakou S; Aka N; Apia NKB; Hammoudi N; Drancourt M; Saad J
    Microbiol Spectr; 2023 Jun; 11(3):e0034223. PubMed ID: 37222600
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protection against Mycobacterium ulcerans lesion development by exposure to aquatic insect saliva.
    Marsollier L; Deniaux E; Brodin P; Marot A; Wondje CM; Saint-André JP; Chauty A; Johnson C; Tekaia F; Yeramian E; Legras P; Carbonnelle B; Reysset G; Eyangoh S; Milon G; Cole ST; Aubry J
    PLoS Med; 2007 Feb; 4(2):e64. PubMed ID: 17326707
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.